SECUKINUMAB PROVIDES RAPID AND SUSTAINED RESOLUTION OF ENTHESITIS IN PSORIATIC ARTHRITIS PATIENTS: POOLED ANALYSIS OF TWO PHASE 3 STUDIES, FUTURE 2 AND FUTURE 3

Coates LC, Mcgonagle D, Schett G, Mease PJ, Quebe-Fehling E, Asquith DL, Rasouliyan L, Mpofu S, Gaillez C (2019)

Publication Type: Conference contribution

Publication year: 2019

Journal

Rheumatology Oxford University Press

Book Volume: 58

Pages Range: 149-149

DOI: 10.1093/rheumatology/kez107.071

Authors with CRIS profile

Georg Schett Lehrstuhl für Innere Medizin III

Involved external institutions

University of Oxford GB United Kingdom (GB) Novartis AG CH Switzerland (CH) RTI Health Solutions US United States (USA) (US) Swedish Medical Center US United States (USA) (US) University of Leeds GB United Kingdom (GB) Novartis UK GB United Kingdom (GB)

How to cite

APA:

Coates, L.C., Mcgonagle, D., Schett, G., Mease, P.J., Quebe-Fehling, E., Asquith, D.L.,... Gaillez, C. (2019). SECUKINUMAB PROVIDES RAPID AND SUSTAINED RESOLUTION OF ENTHESITIS IN PSORIATIC ARTHRITIS PATIENTS: POOLED ANALYSIS OF TWO PHASE 3 STUDIES, FUTURE 2 AND FUTURE 3. (pp. 149-149).

MLA:

Coates, Laura C., et al. "SECUKINUMAB PROVIDES RAPID AND SUSTAINED RESOLUTION OF ENTHESITIS IN PSORIATIC ARTHRITIS PATIENTS: POOLED ANALYSIS OF TWO PHASE 3 STUDIES, FUTURE 2 AND FUTURE 3." 2019. 149-149.

BibTeX: Download